The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COSTEM 2023 | How donor age impacts outcomes in patients with AML undergoing alloSCT
In this video, Wael Saber, MD, MS, Froedtert & Medical College of Wisconsin, Milwaukee, WI, explains the benefits of using younger donors when transplanting patients with acute myeloid leukemia (AML), highlighting the drawbacks of using older donors. This interview took place at The 8th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM 2023), held in Berlin, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
